3 news items
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
VRNA
9 May 24
in multiple major pharmaceutical markets; misconduct or other improper activities by our employees, consultants, principal investigators, third-party service
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
HTGC
VRNA
9 May 24
-controlled approach to investments in credit, private equity, real assets and listed equities. The firm has over 1,200 employees and offices in 23 cities
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
VRNA
2 May 24
pharmaceutical markets; misconduct or other improper activities by our employees, consultants, principal investigators, third-party service providers
- Prev
- 1
- Next